Highlights

Share

Program Content

Activities

  • Preview: AIDS 2022
    My Take on the Most Outstanding Presentations at AIDS 2022
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 13, 2022

    Expires: July 12, 2023

  • Review: AIDS 2022
    HIV Prevention and Treatment Data From AIDS 2022
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 23, 2022

    Expires: August 22, 2023

  • Slides: AIDS 2022
    Key HIV Studies Influencing My Practice Following AIDS 2022
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2022

    Expires: August 16, 2023

  • Audio Recap: AIDS 2022
    Key HIV Studies Influencing My Practice Following AIDS 2022—Audio Redcap
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 04, 2022

    Expires: October 03, 2023

Activities

HPTN 083: Results in TGW
HPTN 083: Safety, Efficacy, and Gender-Affirming Hormonal Therapy Interactions With Long-Acting Injectable CAB for HIV PrEP in Transgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2022

Expires: July 31, 2023

NAMSAL Wk 192 Results
NAMSAL: Wk 192 Results of Dolutegravir-Based vs Low-Dose Efavirenz-Based Regimens as First-line ART in Cameroon
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

SIMPL’HIV Wk 144
SIMPL’HIV Wk 144 Results: Dolutegravir + Emtricitabine vs Standard Combination ART for Maintenance of Virologic Suppression
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 02, 2022

Expires: August 01, 2023

ALLIANCE Study Results
ALLIANCE: Phase III Randomized Controlled Trial of BIC/FTC/TAF vs DTG + FTC/TDF in Treatment-Naive Adults With HIV/HBV Coinfection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

ANDES
ANDES: Generic Fixed-Dose DRV/RTV in Combination With 3TC vs 3TC/TDF for Initial HIV Treatment
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

TB-PRACTECAL
TB-PRACTECAL: Efficacy and Safety of Three 24-Wk Oral Regimens for Pulmonary Rifampicin-Resistant TB in Persons With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

6-Mo PrEP + HIVST
Effect of 6-Mo PrEP Dispensing Plus HIV Self-Testing on 12-Mo PrEP Continuation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

VRC01 in Infants
IMPAACT 2008: Broadly Neutralizing Antibody VRC01 Plus ART in Infants With HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2022

Expires: August 04, 2023

DoxyPEP: Doxycycline STI PEP
DoxyPEP: Prevention of STIs With Doxycycline PEP Among MSM and TGW With HIV or Receiving PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

HPTN 084: CAB in Cisgender Women
HPTN 084 Update: Long-Acting Injectable CAB vs Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 03, 2022

Expires: August 02, 2023

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner